Lyra Therapeutics Inc (LYRA)
0.3749
-0.01
(-3.33%)
USD |
NASDAQ |
May 10, 15:14
Lyra Therapeutics Profit Margin (Quarterly): -4.22K% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -4.22K% |
| December 31, 2023 | -10.38K% |
| September 30, 2023 | -2.88K% |
| June 30, 2023 | -3.41K% |
| March 31, 2023 | -3.96K% |
| December 31, 2022 | -129.4K% |
| Date | Value |
|---|---|
| September 30, 2022 | -4.11K% |
| June 30, 2022 | -2.74K% |
| March 31, 2022 | -2.55K% |
| December 31, 2021 | -5.02K% |
| September 30, 2021 | -78.96K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-129.4K%
Minimum
Dec 2022
-2.55K%
Maximum
Mar 2022
-22.51K%
Average
-4.11K%
Median
Sep 2022
Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 12.23% |
| Xtant Medical Holdings Inc | -15.31% |
| Asensus Surgical Inc | -317.3% |
| Myomo Inc | -51.72% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -82.82% |
| Return on Assets | -55.17% |
| Return on Invested Capital | -82.82% |
| Operating Margin (Quarterly) | -4.42K% |
| Return on Net Operating Assets | -354.0% |